Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Uterine Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Kidney Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1

Interventions

pembrolizumab 11Specimen Handling 4X-Rays 3Nivolumab 3Ipilimumab 3Immunoglobulin G 3Biopsy 3temsirolimus 2sargramostim 2epacadostat 2capivasertib 2Taxes 2Paclitaxel 2Metformin 2Magnetic Resonance Spectroscopy 2Disulfides 2Cyclophosphamide 2Blood Specimen Collection 2zimberelimab 1veliparib 1ulixertinib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1toripalimab 1spartalizumab 1sonidegib 1sapanisertib 1relatlimab 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Health × Dermatologic × Clear all
NCT01447199 2020-01-07

The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)

M.D. Anderson Cancer Center

Unknown
2,000 enrolled
DermatologicGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Kidney Neoplasms, Skin Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡